NCT04459273 2026-02-05
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Phase 1 Active not recruiting
Clinical Trials
7 trialsNCT04888988 2025-11-21
CIPN
University of Rochester
Phase NA Active not recruiting
NCT02862275 2025-10-23
Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT05600556 2025-05-15
Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)
Thomas Jefferson University
Phase NA Withdrawn
NCT01902173 2025-01-14
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT03980535 2022-10-28
New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality
M.D. Anderson Cancer Center
Phase NA Completed
NCT04605614 2022-06-09
64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression
City of Hope Medical Center
Phase 1 Withdrawn